China authorizes Livzon Pharma’s COVID-19 vaccine for emergency use
New protein-based vaccine to be used as booster jab, local media reports.
Abone Ol
China has approved Livzon Pharmaceutical Group's COVID-19 vaccine for emergency use, local media reported on Saturday.
Livzon’s protein-based vaccine is the eighth domestically developed vaccine that will be used as a booster shot in the country where nearly 90% of the population have received their primary vaccinations, according to Caixin Global’s website.
Most Read News
-
Israeli army carries out 2 explosions on outskirts of
-
37 killed, over 40 injured in Russian drone strike on
-
WHO reports 5,794 Ebola cases and 2,786 deaths in Congo
-
Zelenskyy says US has given information to Ukraine about
-
Iran transfers $7.5B in oil revenues to central bank
-
US secures majority control of 65B barrels of Venezuelan
-
Iranian president urges Trump to avoid creating turmoil
-
Up to 3,000 people forcibly disappeared in Gaza during
